(Q43728520)

26 November 2017

title

Splice variant HE4-V3 expression is associated with favorable prognosis in pulmonary adenocarcinoma (English)

1 reference

26 November 2017

1 reference

Keita Tokuishi

1

1 reference

26 November 2017

Shin-ichi Yamashita

series ordinal

2

1 reference

26 November 2017

Kazuyuki Ohbo

series ordinal

3

1 reference

26 November 2017

Katsunobu Kawahara

series ordinal

4

1 reference

26 November 2017

publication date

21 October 2011

1 reference

26 November 2017

1 reference

26 November 2017

volume

33

1 reference

26 November 2017

issue

1

1 reference

26 November 2017

page(s)

103-109

1 reference

https://scigraph.springernature.com/pub.10.1007/s13277-011-0252-8

26 November 2017

exact match

0 references

cites work

Revisions in the International System for Staging Lung Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0252-8

The putative ovarian tumour marker gene HE4 (WFDC2), is expressed in normal tissues and undergoes complex alternative splicing to yield multiple protein isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0252-8

Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0252-8

Comparative hybridization of an array of 21,500 ovarian cDNAs for the discovery of genes overexpressed in ovarian carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0252-8

Ovarian tumor marker HE4 is differently expressed during the phases of the menstrual cycle in healthy young women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0252-8

Detection of the HE4 protein in urine as a biomarker for ovarian neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0252-8

WFDC2 (HE4): a potential role in the innate immunity of the oral cavity and respiratory tract and the development of adenocarcinomas of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0252-8

Prognostic significance of HE4 expression in pulmonary adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0252-8

In vivo expression of survivin and its splice variant survivin-2B: impact on clinical outcome in acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0252-8

Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0252-8

Bead-based ELISA for validation of ovarian cancer early detection markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0252-8

Proteins with whey-acidic-protein motifs and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0252-8

Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0252-8

Transcriptional targeting in ovarian cancer cells using the human epididymis protein 4 promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0252-8

Comprehensive analysis of HE4 expression in normal and malignant human tissues

21 January 2018

1 reference

12 December 2020

HE4: a new potential early biomarker for the recurrence of ovarian cancer

1 reference

12 December 2020

Elafin: an elastase-specific inhibitor of human skin. Purification, characterization, and complete amino acid sequence

1 reference

12 December 2020

The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma.

1 reference

12 December 2020

10.1007/S13277-011-0252-8

Identifiers

DOI

1 reference

Dimensions Publication ID

26 November 2017

1011682070

0 references

1 reference